Mingpeng Zhang
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Integrative bulk and single-cell transcriptomic analysis identifies a migrasome-associated lncRNA signature predictive of prognosis and immune landscape in clear cell renal cell carcinoma.
Journal: Frontiers in immunology
Published: May 31, 2025
P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 20, 2023
TEAD3 inhibits the proliferation and metastasis of prostate cancer via suppressing ADRBK2.
Journal: Biochemical and biophysical research communications
Published: February 16, 2023
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.
Journal: Cell death & disease
Published: September 28, 2022
Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma.
Journal: Frontiers in genetics
Published: March 01, 2022
LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance.
Journal: Cell death & disease
Published: June 06, 2021
Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC.
Journal: Oncogene
Published: May 31, 2021
TPX2 mediates prostate cancer epithelial-mesenchymal transition through CDK1 regulated phosphorylation of ERK/GSK3β/SNAIL pathway.
Journal: Biochemical and biophysical research communications
Published: January 16, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026